Valspodar
Alternative Names: Amdray; PSC 833; SDZ PSC 833Latest Information Update: 24 Oct 2021
At a glance
- Originator Novartis
- Class Antineoplastics
- Mechanism of Action P-glycoprotein inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Acute myeloid leukaemia; Breast cancer; Cancer; Multiple myeloma; Ovarian cancer; Renal cancer